In its first major move since acquiring control of Applied Circuit Technology, Locke-Sweatman Investments of Austin, Tex., said it has appointed a new president to head up the company's generic pharmaceuticals subsidiary, Gardena-based Whiteworth International Inc.
The Texas partnership, which bought 33% of Anaheim-based ACT last month, has named Dale Garlow, 45, a former Upjohn Co. executive, to fill the seat vacated by Walter R. Menetrey. Menetrey, who was ACT's president and chief operating officer, had also acted as head of the subsidiary. He left ACT in September, a day after the company reported the biggest nine-month loss in its history.
Garlow comes to Whiteworth after 20 years with Upjohn Co., the giant Kalamazoo, Mich., pharmaceutical company. Most recently, he oversaw the company's North-Central division, which is based in Kalamazoo.
"Mr. Garlow has been a business associate for a number of years and we . . . determined that his experience with Upjohn over the last 20 years would be instrumental in taking Whiteworth to a profitable future," said Don M. Sweatman, ACT's chairman and chief executive officer.